{
  "title": "Paper_1223",
  "abstract": "pmc Pathogens Pathogens 2622 pathogens pathogens Pathogens 2076-0817 Multidisciplinary Digital Publishing Institute  (MDPI) PMC12472219 PMC12472219.1 12472219 12472219 41011778 10.3390/pathogens14090878 pathogens-14-00878 1 Article Optimization of (Dithioperoxo)thiolate-Based Antifungal Agents for Triazole-Resistant Aspergillus Fumigatus Karuturi Surya Investigation Data curation Writing – review & editing Jobe Kaitlyn L. Varney Melinda E. Hambuchen Michael D. https://orcid.org/0000-0001-9144-2960 Amin A. R. M. Ruhul Methodology Formal analysis Investigation Resources Data curation Writing – review & editing https://orcid.org/0000-0003-0213-4726 Long Timothy E. * Konaklieva Monika I. Academic Editor Plotkin Balbina J. Academic Editor Department of Pharmaceutical Sciences, School of Pharmacy, Marshall University, Huntington, WV 25755, USA; karuturi@marshall.edu kaitlyn.jobe99@gmail.com varney31@marshall.edu hambuchen@marshall.edu amina@marshall.edu * longt@marshall.edu 03 9 2025 9 2025 14 9 497659 878 07 8 2025 25 8 2025 26 8 2025 03 09 2025 27 09 2025 29 09 2025 © 2025 by the authors. 2025 https://creativecommons.org/licenses/by/4.0/ Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/ This investigation on novel antifungal agents featuring a thiol-reactive (dithioperoxo)thiolate chemical nucleus [-NC(S)S-SR] established that the optimal levels of fungal growth inhibition were achieved with thiomethyl-bound derivatives (R = Me). The most efficacious analogs had MIC 50 90 A. fumigatus 2+ A. fumigatus antimicrobial discovery antifungal Aspergillus disulfides National Institutes of Health R15AI151970 R15DE032063 This work was supported by funding from the National Institutes of Health grants R15AI151970 (TEL) and R15DE032063 (ARMRA). pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes 1. Introduction Aspergillus 1 Aspergillus A. fumigatus 2 3 A. fumigatus 3 4 5 6 To this end, the agricultural use of azole fungicides has largely contributed to the emergence of triazole-resistant A. fumigatus cyp51A 7 cdr1B A. fumigatus 8 3 3 Drug repurposing and repositioning are effective strategies to develop a new treatment from a pre-existing medication with established human pharmacokinetic and safety data. In a recent report, Shanholtzer and coworkers disclosed that fluconazole-resistant Candida auris Candida glabrata ® 9 Figure 1 n+ 2+ 3+ 10 11 12 2+ Candida 2 9 The findings of this research prompted us to evaluate (dithioperoxo)thiolate analogs of disulfiram ( Figure 1 Candida albicans 13 S N N N N C. albicans A. fumigatus 50 90 2. Materials and Methods 2.1. Synthesis Chemicals were obtained from Thermo Fisher Scientific (Waltham, MA, USA) or VWR international (Radnor, PA, USA) and used without further purification. Reactions were monitored by thin-layer chromatography (TLC) using GF 254 ® 1 13 2.1.1. Preparation of Carbamo(dithioperoxo)thiolates ( 1a–d Disulfiram (200 mg, 0.68 mmol) and the appropriate mercaptan (0.74 mmol) were reacted in a seal tube at 60 °C in 2 mL of anhydrous dimethylformamide (DMF) [ 13 14 4 13 14 2.1.2. Preparation of N 2 Sulfuryl chloride (2.4 g, 18 mmol) in 5 mL of CH 2 2 2 2 15 2 2 4 N 15 16 N 2a 2 R f 1 3 13 3 m z N 2b 2 R f 1 3 J J 13 3 m z 2.1.3. Preparation of Carbamo(dithioperoxo)thiolates ( 1e–i Carbon disulfide (60 µL, 1.1 mmol) was added dropwise to a stirring solution of amine (0.9 mmol) and KOH powder (51 mg, 1 mmol) in diethyl ether (2 mL) at 0 °C. After 1 h, the solvent was evaporated under reduced pressure. The K + N 13 14 methyl dimethylcarbamo(dithioperoxo)thioate ( 1e 2 R f 1 3 13 3 m z methyl diethylcarbamo(dithioperoxo)thioate ( 1f 2 R f 1 3 J J J 13 3 m z ethyl dimethylcarbamo(dithioperoxo)thioate ( 1g 1 3 J 13 3 m/z ethyl benzyl(methyl)carbamo(dithioperoxo)thioate ( 1h 1 3 13 3 m/z methyl methoxy(methyl)carbamo(dithioperoxo)thioate ( 1i 2 R f 1 3 13 3 m z 2.1.4. Preparation of Carbano(dithioperoxo)thioates ( 3 Carbon disulfide (54 µL, 0.9 mmol) was added dropwise to a stirring solution of alkyl alcohol (0.9 mmol) and KOH powder (51 mg, 1 mmol) in diethyl ether (5 mL) at 0 °C. After 1 h, the solvent was evaporated under reduced pressure. The K + N 17 18 (methoxy(thiocarbonyl))methyldisulfane ( 3a 2 R f 1 3 J J 13 3 (ethoxy(thiocarbonyl))methyldisulfane ( 3b 2 R f 1 3 J 13 3 2.2. Antimicrobial Studies Growth media and antifungal agents were obtained from commercial vendors and used without further purification. Powder Gibco Roswell Park Memorial Institute (RPMI) 1640 medium with L-glutamine and phenol red (ref. 31800-105) was obtained from Thermo Fisher Scientific. Amphotericin B (CAS 1397-89-3) and disulfiram (97%, CAS 97-77-8) were obtained from Alfa Aesar via Thermo Fisher Scientific. Fluconazole (≥98%, CAS 86386-73-4) and voriconazole (≥98%, CAS 137234-62-9) were obtained from TCI America via VWR International. 2.2.1. MIC Determination Susceptibility testing was performed by the microdilution assay method in 96-well plate format according to CLSI protocols [ 19 20 A. fumigatus A. fumigatus 530 3 A. fumigatus 4 Candida A. fumigatus Cryptococcus neoformans 2.2.2. Growth Studies The effect of the (dithioperoxo)thiolates on A. fumigatus 5 ® 530 530 2.2.3. Checkerboard Studies Isobologram analysis was performed with A. fumigatus 21 4 A. fumigatus 530 2.3. Cytotoxicity Studies 2.3.1. IC 50 The in vitro cytotoxicity was determined against two human cell lines (HEK293T and MDA686TU) using the sulforhodamine B (SRB) colorimetric assay [ 22 2 3 3 2 492 50 2.3.2. Hematological Analysis Trunk blood was collected in EDTA tubes from a male Sprague Dawley rat (Hilltop Lab Animals, Scottdale, PA, USA) and used within 3 h of the study. The blood (46 µL) was dispensed in 1.5 mL centrifuge tubes containing 1.25 mM of the test agents in 4 µL of DMSO. The samples were incubated at 37 °C with gentle agitation (200 rpm). Complete blood counts were analyzed using a Hemavet 950FS (Drew Scientific, Plantation, FL, USA) after 2 h. The log 2 2 t p 3. Results 3.1. (Dithioperoxo)thiolate Synthesis The strategies employed to synthesize the (dithioperoxo)thiolates for the investigation are depicted in Figure 2 1a–d Figure 2 1e–i Figure 2 N N 2 N 3a 3b Figure 2 3.2. Susceptibility Testing The MICs were determined according to protocols set forth by CLSI reference methods M27-A4 [ 19 20 Candida A. fumigatus Cryptococcus neoformans Table 1 1a–d Candida C. neoformans A. fumigatus S 1a S 1b S 1c S 1d 1a A. fumigatus The investigation then proceeded to focus on the S S Table 2 N N 1e 1f 1g 3a 3b A. fumigatus S 1e S 1a 2 1f 1g S 1e 1f A. fumigatus Candida S 1a 1g 1h Afterwards, the (dithioperoxo)thiolates exhibiting MICs of ≤10 µM were evaluated against a ten-member A. fumigatus Table 3 S 1e 1f S 1a 1g S 1e 1f 1a 1e Table 3 A. fumigatus 2 3.3. Pharmacodynamic Studies The S 1e 1f 50 90 A. fumigatus A. fumigatus Figure 3 1f 1e In the A. fumigatus 23 A. fumigatus 1e 1f Figure 3 A. fumigatus In a prior report, Shanholtzer et al. established that DETC•Na and Cu 2+ Candida glabrata Candida auris 9 1e 2+ A. fumigatus 21 24 2+ Figure 4 2+ 1e Figure 4 As illustrated in Figure 1 1e 25 A. fumigatus 1e Figure 4 Figure 4 1e 3.4. Cytotoxicity Studies The in vitro cytotoxic activities of the lead (dithioperoxo)thiolates 1e 1f 50 22 50 1e 26 2 2 2 p 1e p p 4. Discussion The primary objective of this research was to identify lead (dithioperoxo)thiolates as antifungal agents against A. fumigatus C. albicans Acinetobacter baumannii S 13 14 Staphylococcus aureus, S S 13 14 C. albicans S 1e 1f 90 A. fumigatus The ensuing pharmacodynamic studies revealed that compounds 1e 1f A. fumigatus Figure 3 1e 2+ 2+ A. fumigatus 27 2+ Figure 4 A. fumigatus 28 Studies on the mechanisms of antifungal action of (dithioperoxo)thiolates will be a focus of future research. Previous investigations into the antibacterial mechanisms of disulfiram and the natural thiosulfinate allicin (garlic) should allow us to glean information on the antimicrobial pharmacology in fungi. The thiol-reactive compounds [ 29 S. aureus 12 30 Escherichia coli S 31 As in the case of disulfiram, the DATC metabolite is expected to play a role in the mechanism of antifungal action. Prior differential transcriptomics and bioenergetic studies implicated DETC in the antibacterial action of disulfiram as an inhibitor of oxidative phosphorylation in S. aureus 12 S. aureus 12 A. fumigatus 32 As with other thiol-reactive disulfides [ 29 33 34 5. Conclusions This research established the S S 1e 10 35 Acknowledgments Candida Aspergillus C. neoformans Disclaimer/Publisher’s Note: Author Contributions Conceptualization—T.E.L.; Investigation—S.K., K.L.J., M.E.V., A.R.M.R.A. and T.E.L.; Methodology—M.E.V., A.R.M.R.A. and T.E.L.; Data Curation—S.K., K.L.J., M.E.V., A.R.M.R.A. and T.E.L.; Formal Analysis—M.E.V., A.R.M.R.A. and T.E.L.; Resources—M.E.V., M.D.H., A.R.M.R.A. and T.E.L.; Funding Acquisition—T.E.L.; Writing—Original Draft—T.E.L.; Writing—Review and Editing—S.K., M.E.V., M.D.H., A.R.M.R.A. and T.E.L. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement The animal study protocol was approved by the Institutional Animal Care and Use Committee of Marshall University (protocol #855 approved on 6 March 2025). Informed Consent Statement Not applicable. Data Availability Statement The original contributions are included in the article; further inquiries can be directed to the corresponding author. Conflicts of Interest The authors declare no conflict of interest. References 1. Segal B.H. Walsh T.J. Current approaches to diagnosis and treatment of invasive aspergillosis Am. J. Respir. Crit. Care Med. 2006 173 707 717 10.1164/rccm.200505-727SO 16387806 2. Brown G.D. Denning D.W. Gow N.A. Levitz S.M. Netea M.G. White T.C. Hidden killers: Human fungal infections Sci. Transl. Med. 2012 4 165rv13 10.1126/scitranslmed.3004404 23253612 3. Patterson T.F. Thompson G.R. 3rd Denning D.W. Fishman J.A. Hadley S. Herbrecht R. Kontoyiannis D.P. Marr K.A. Morrison V.A. Nguyen M.H. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America Clin. Infect. Dis. 2016 63 e1 e60 10.1093/cid/ciw326 27365388 PMC4967602 4. Lewis J.S. 2nd Wiederhold N.P. Hakki M. Thompson G.R. 3rd New Perspectives on Antimicrobial Agents: Isavuconazole Antimicrob. Agents Chemother. 2022 66 e0017722 10.1128/aac.00177-22 35969068 PMC9487460 5. CLSI Voriconazole Breakpoints for Aspergillus fumigatus, 1st ed CLSI rationale document FR01; Clinical and Laboratory Standard Institute Wayne, PA, USA 2024 978-1-68440-230-4 6. Slavin M.A. Chen Y.-C. Cordonnier C. Cornely O.A. Cuenca-Estrella M. Donnelly J.P. Groll A.H. Lortholary O. Marty F.M. Nucci M. When to Change Treatment of Acute Invasive Aspergillosis: An Expert Viewpoint J. Antimicrob. Chemother. 2021 77 16 23 10.1093/jac/dkab317 34508633 PMC8730679 7. Berger S. El Chazli Y. Babu A.F. Coste A.T. Azole Resistance in Aspergillus fumigatus Front. Microbiol. 2017 8 1024 10.3389/fmicb.2017.01024 28638374 PMC5461301 8. Hagiwara D. Watanabe A. Kamei K. Goldman G.H. Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Front. Microbiol. 2016 7 1382 10.3389/fmicb.2016.01382 27708619 PMC5030247 9. Shanholtzer C.N. Rice C. Watson K. Carreon H. Long T.E. Effect of copper on the antifungal activity of disulfiram (Antabuse ® Candida Med. Mycol. 2022 60 myac016 10.1093/mmy/myac016 35188195 PMC8929679 10. Custodio M.M. Sparks J. Long T.E. Disulfiram: A Repurposed Drug in Preclinical and Clinical Development for the Treatment of Infectious Diseases Antiinfect. Agents 2022 20 e040122199856 10.2174/2211352520666220104104747 35782673 PMC9245773 11. Frazier K.R. Moore J.A. Long T.E. Antibacterial activity of disulfiram and its metabolites J. Appl. Microbiol. 2019 126 79 86 10.1111/jam.14094 30160334 12. Long T.E. Naidu S.T. Hissom E.G. Meka Y. Chavva H. Brown K.C. Valentine M.E. Fan J. Denvir J. Primerano D.A. Disulfiram induces redox imbalance and perturbations in central glucose catabolism and metal homeostasis to inhibit the growth of Staphylococcus aureus Sci. Rep. 2025 15 15658 10.1038/s41598-025-00078-3 40325037 PMC12053631 13. Lewis A.D. Riedel T.M. Kesler M.B.A. Varney M.E. Long T.E. Pharmacological evaluation of disulfiram analogs as antimicrobial agents and their application as inhibitors of fosB-mediated fosfomycin resistance J. Antibiot. 2022 75 146 154 10.1038/s41429-022-00500-2 35058577 PMC8852335 14. Sheppard J.G. Frazier K.R. Saralkar P. Hossain M.F. Geldenhuys W.J. Long T.E. Disulfiram-based disulfides as narrow-spectrum antibacterial agents Bioorg. Med. Chem. Lett. 2018 28 1298 1302 10.1016/j.bmcl.2018.03.023 29571571 PMC5893419 15. Sheppard J.G. Long T.E. Allicin-inspired thiolated fluoroquinolones as antibacterials against ESKAPE pathogens Bioorg. Med. Chem. Lett. 2016 26 5545 5549 10.1016/j.bmcl.2016.10.002 27756563 16. Heldreth B. Long T.E. Jang S. Reddy G.S.K. Turos E. Dickey S. Lim D.V. N N Bioorg. Med. Chem. 2006 14 3775 3784 10.1016/j.bmc.2006.01.029 16480881 17. Satyanarayana A.N.V. Pattanayak P. Nayar P.P. Chatterjee T. Iodine-mediated, chalcogen–chalcogen bond formation in water: Green synthesis of carbamo(dithioperoxo)thioates, carbamo(selenothioperoxo)thioates, carbono(dithioperoxo)thioates, and carbono(selenothioperoxo)thioates Green Chem. 2025 27 1054 1061 10.1039/D4GC04699D 18. Schroll A.L. Eastep S.J. Barany G. Synthesis and characterization of methoxy(thiocarbonyl)sulfenyl chloride J. Org. Chem. 1990 55 1475 1479 10.1021/jo00292a018 19. CLSI Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts 4th ed. CLSI standard M27; Clinical and Laboratory Standard Institute Wayne, PA, USA 2017 20. CLSI Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi 3rd ed. CLSI standard M38; Clinical and Laboratory Standard Institute Wayne, PA, USA 2017 21. Moody J.A. Synergism testing: Broth microdilution checkboard and broth macrodilution methods Clinical Procedures Handbook Isenberg H.D. ASM Press Washington, DC, USA 1992 5.18.1 5.18.28 22. Adeluola A.A. Bosomtwe N. Long T.E. Amin A.R.M.R. Context-dependent activation of p53 target genes and induction of apoptosis by actinomycin D in aerodigestive tract cancers Apoptosis 2022 27 342 353 10.1007/s10495-022-01720-5 35267106 PMC9133209 23. Dagenais T.R. Keller N.P. Pathogenesis of Aspergillus fumigatus Clin. Microbiol. Rev. 2009 22 447 465 10.1128/CMR.00055-08 19597008 PMC2708386 24. Chavva H. Meka Y. Long T.E. Antimicrobial pharmacodynamics of vancomycin and disulfiram (Antabuse ® Staphylococcus aureus Front. Microbiol. 2023 13 1092257 10.3389/fmicb.2022.1092257 36687633 PMC9854118 25. Sato I. Shimizu M. Hoshino T. Takaya N. The glutathione system of Aspergillus nidulans S J. Biol. Chem. 2009 284 8042 8053 10.1074/jbc.M807771200 19171936 PMC2658098 26. Yu Y. Chen P. Gao M. Lan W. Sun S. Ma Z. Sultani R. Cui Y. Umar M.N. Khan S.W. Amphotericin B Tamed by Salicylic Acid ACS Omega 2022 7 14690 14696 10.1021/acsomega.1c07201 35557655 PMC9088917 27. Handelman M. Meir Z. Shadkchan Y. Kandil A.A. Amano O. Mariscal M. López-Berges M.S. Osherov N. Mitchell A.P. Evolution of the pathogenic mold Aspergillus fumigatus mSphere 2024 9 e0025324 10.1128/msphere.00253-24 38814077 PMC11332344 28. Baselt R.C. Sunderman F.W. Jr. Mitchell J. Horak E. Comparisons of antidotal efficacy of sodium diethyldithiocarbamate, D-penicillamine and triethylenetetramine upon acute toxicity of nickel carbonyl in rats Res. Commun. Chem. Pathol. Pharmacol. 1977 18 677 688 200993 29. Blume L. Long T.E. Turos E. Applications and Opportunities in Using Disulfides, Thiosulfinates, and Thiosulfonates as Antibacterials Int. J. Mol. Sci. 2023 24 8659 10.3390/ijms24108659 37240003 PMC10218091 30. Loi V.V. Huyen N.T.T. Busche T. Tung Q.N. Gruhlke M.C.H. Kalinowski J. Bernhardt J. Slusarenko A.J. Antelmann H. Staphylococcus aureus S Free Radic. Biol. Med. 2019 139 55 69 10.1016/j.freeradbiomed.2019.05.018 31121222 31. Müller A. Eller J. Albrecht F. Prochnow P. Kuhlmann K. Bandow J.E. Slusarenko A.J. Leichert L.I. Allicin Induces Thiol Stress in Bacteria through S J. Biol. Chem. 2016 291 11477 11490 10.1074/jbc.M115.702308 27008862 PMC4882420 32. Baltussen T.J.H. Zoll J. Verweij P.E. Melchers W.J.G. Molecular Mechanisms of Conidial Germination in Aspergillus Microbiol Mol. Biol. Rev. 2019 84 e00049-19 10.1128/MMBR.00049-19 PMC6903801 31801804 33. Wu G. Fang Y.Z. Yang S. Lupton J.R. Turner N.D. Glutathione metabolism and its implications for health J. Nutr. 2004 134 489 492 10.1093/jn/134.3.489 14988435 34. Liu X. Testa B. Fahr A. Lipophilicity and its relationship with passive drug permeation Pharm. Res. 2011 28 962 977 10.1007/s11095-010-0303-7 21052797 35. Johansson B. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites Acta Psychiatr. Scand. Suppl. 1992 369 15 26 10.1111/j.1600-0447.1992.tb03310.x 1471547 Figure 1 Thiol-disulfide exchange reactions of thiols (RSH) with disulfiram and (dithioperoxo)thiolates. ( a N N n n+ b N N n n+ c n Figure 2 Synthesis of (dithioperoxo)thiolates. ( a 1a–d b 1e–i N 2 c 3a 3b N Figure 3 Growth response curves for a 1 to 5 × 10 5 A. fumigatus left right Figure 4 Pharmacodynamic studies on (dithioperoxo)thiolate 1e 2+ a A. fumigatus b 1e 2+ pathogens-14-00878-t001_Table 1 Table 1 Antifungal activity of diethylcarbamo(dithioperoxo)thioate derived from disulfiram. Compd n Species a C. albicans b C. glabrata b C. krusei b C. tropicalis b C. auris b C. neoformans c A. fumigatus c  1a 1 0.5 (2) 1 (5) 0.5 (2) 1 (5) 2 (10) 1 (5) 2 (10)  1b 3 1 (2) 2 (8) 2 (8) 2 (8) 4 (17) 1 (4) 4 (17)  1c 5 1 (4) 2 (8) 2 (8) 2 (8) 4 (15) 1 (4) 8 (30)  1d 7 2 (7) 2 (7) 4 (17) 16 (55) 16 (55) 2 (7) >32 (>109) disulfiram  1 (3) 8 (27) 1 (3) 8 (27) 2 (7) 8 (27) >16 (>54) fluconazole  >16 (>52) >16 (>52) >16 (>52) >16 (>52) >16 (>52) 8 (23) >16 (>52) voriconazole  >16 (>45) 4 (12) 2 (6) 8 (23) 1 (3) ≤0.5 (≤1) 4 (12) amphotericin B  1 (1) 0.5 (0.5) 1 (1) 1 (1) 1 (1) 0.5 (0.5) 1 (1) a b c pathogens-14-00878-t002_Table 2 Table 2 Antifungal activity of (dithioperoxo)thiolates derived from potassium dithiocarbamates and xanthates. Compd R R’ n Species|Modal MIC: µg/mL (µM) C. albicans a C. glabrata a C. krusei a C. tropicalis a C. auris a C. neoformans b A. fumigatus b  1e Et Et 0 1 (5) 0.5 (3) 1 (5) 0.5 (3) 1 (5) 2 (10) 2 (10)  1f Me Me 0 1 (6) 2 (12) 2 (12) 2 (12) 2 (12) 2 (12) 1 (6)  1g Me Me 1 0.5 (3) 1 (6) 1 (6) 1 (6) 1 (6) 1 (6) 1 (6)  1h Me Bn 1 1 (4) 0.5 (2) 0.5 (2) 2 (8) 2 (8) 0.5 (2) 4 (16)  1i Me MeO 0 1 (6) 1 (5.5) 1 (6) 2 (11) 1 (6) 4 (22) 4 (22)  3a Me  0 16 (104) 8 (52) 16 (104) 16 (104) 8 (52) 8 (52) >16 (>104)  3b Et  0 16 (95) 8 (48) 16 (95) 16 (95) 8 (48) 8 (48) >16 (>95) a b pathogens-14-00878-t003_Table 3 Table 3 Susceptibility of characterized isolates of voriconazole-resistant A. fumigatus Strain Cyp51A Mutation Compd|Modal MIC: µg/mL (µM) 1a 1e 1f 1g DETC•Na a Voriconazole AR-0732 F495I, L98H, S297T, TR34 2 (10) 2 (10) 1 (6) 2 (11) >16 (>71) 2 (6) AR-0733 L98H, TR34 2 (10) 2 (10) 1 (6) 1 (6) >16 (>71) 4 (12) AR-0734 L98H, TR34 4 (19) 2 (10) 1 (6) 4 (22) >16 (>71) 4 (12) AR-0735 F495I, L98H, S297T, TR34 2 (10) 2 (10) 1 (6) 2 (11) >16 (>71) 2 (6) AR-1283 M220V 2 (10) 2 (10) 2 (12) 1 (6) >16 (>71) 1 (3) AR-1292 M220K 2 (10) 2 (10) 2 (12) 1 (6) >16 (>71) 2 (6) AR-1293 G54R 1 (5) 1 (5) 2 (12) 1 (6) >16 (>71) 2 (6) AR-1294 T289A, TR46, Y121 1 (5) 1 (5) 2 (12) 2 (11) ≥16 (≥71) >16 (>45) AR-1295 T289A, TR46, Y121 4 (19) 2 (10) 2 (12) 4 (22) ≥16 (≥71) >16 (>45) AR-1296 T289A, TR46, Y121 1 (5) 1 (5) 2 (12) 4 (22) >16 (>71) >16 (>45) a ",
  "metadata": {
    "Title of this paper": "A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites",
    "Journal it was published in:": "Pathogens",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12472219/"
  }
}